- About About
Medical Patient Resources Cannabis Care Certification Patient's Guide to Medical Cannabis Patient's Guide to CBD Talking to your doctor Become a Legal Medical Marijuana Patient The Medical Cannabis Patient’s Guide for U.S. Travel Guide to Using Medical Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Arthritis and Medical Cannabis Cancer and Medical Cannabis Chronic Pain and Medical Cannabis Gastrointestinal Disorders and Medical Cannabis HIV/AIDS and Medical Cannabis Movement Disorders and Medical Cannabis Multiple Sclerosis and Medical Cannabis Aging and Medical Cannabis Veterans and Medical Cannabis Medical Marijuana Conditions in Your Area Growing Cannabis Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources Medical Cannabis Continuing Medical Education (CME) Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Policy Positions Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Data Quality Act Briefs Fact Sheet on ASA's Data Quality Act Petition to HHS ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2021 State of the States Cannabis and Cannabis Resin- Critical Review Preparation Document Medical Cannabis in America
- News News
- Join Join
Policy Recommendations Rhode Island
2020-21 Improvements and Recommendations
Rhode Island’s legislators have been busy debating cannabis legalization for all adults over 21 in the 2021 legislative session; three separate bills aiming for that goal are being debated by the state’s legislators. Meanwhile, the state’s medical cannabis regulations implemented new third-party testing guidelines in late 2020. While limited in scope, the new guidelines are certainly an improvement over the state’s previously lackluster safety standards.
As part of a larger program expansion, Rhode Island’s regulators awarded 5 new dispensary licenses in October 2021 to more than double the state’s retail capacity. Regulators in Rhode Island also chose to expand the state’s product safety standards at the beginning of 2021 to include product testing for potency, heavy metals, and microbiological contaminants. For the time being, Rhode Island’s emergency COVID guidelines remain in place.
2021 saw modest growth in enrollment for Rhode Island’s patient registry. With about 2,000 more patients registered than there were during our last report, the state still falls just short of the 20,000-patient mark.
In 2022, legislators should focus on expanding protections for patients including against discrimination in custody hearings and family court, in medical procedures involving organ transplants, and from roadside sobriety tests. Legislators should also look to create an independent review body consisting of patients and caregivers that would help state regulators address patient concerns.